Elisa A. Waxman, Ph.D. - Publications

Affiliations: 
2006 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Neuroscience Biology, Molecular Biology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Emmer KL, Waxman EA, Covy JP, Giasson BI. E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment. The Journal of Biological Chemistry. 286: 35104-18. PMID 21846727 DOI: 10.1074/Jbc.M111.247965  0.353
2011 Waxman EA, Giasson BI. Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 7604-18. PMID 21613474 DOI: 10.1523/Jneurosci.0297-11.2011  0.37
2011 Waxman EA, Giasson BI. Characterization of kinases involved in the phosphorylation of aggregated α-synuclein. Journal of Neuroscience Research. 89: 231-47. PMID 21162130 DOI: 10.1002/Jnr.22537  0.346
2010 Waxman EA, Giasson BI. A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation. Journal of Neurochemistry. 113: 374-88. PMID 20132485 DOI: 10.1111/J.1471-4159.2010.06592.X  0.418
2010 Waxman EA, Emmer KL, Giasson BI. Residue Glu83 plays a major role in negatively regulating alpha-synuclein amyloid formation. Biochemical and Biophysical Research Communications. 391: 1415-20. PMID 20026050 DOI: 10.1016/J.Bbrc.2009.12.079  0.409
2009 Waxman EA, Mazzulli JR, Giasson BI. Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization. Biochemistry. 48: 9427-36. PMID 19722699 DOI: 10.1021/Bi900539P  0.412
2009 Waxman EA, Covy JP, Bukh I, Li X, Dawson TM, Giasson BI. Leucine-rich repeat kinase 2 expression leads to aggresome formation that is not associated with alpha-synuclein inclusions. Journal of Neuropathology and Experimental Neurology. 68: 785-96. PMID 19535993 DOI: 10.1097/Nen.0B013E3181Aaf4Fd  0.444
2009 Waxman EA, Giasson BI. Molecular mechanisms of alpha-synuclein neurodegeneration. Biochimica Et Biophysica Acta. 1792: 616-24. PMID 18955133 DOI: 10.1016/J.Bbadis.2008.09.013  0.407
2008 Waxman EA, Giasson BI. Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. Journal of Neuropathology and Experimental Neurology. 67: 402-16. PMID 18451726 DOI: 10.1097/Nen.0B013E3186Fc995  0.421
2008 Waxman EA, Duda JE, Giasson BI. Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions. Acta Neuropathologica. 116: 37-46. PMID 18414880 DOI: 10.1007/S00401-008-0375-1  0.399
2007 Waxman EA, Baconguis I, Lynch DR, Robinson MB. N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1. The Journal of Biological Chemistry. 282: 17594-607. PMID 17459877 DOI: 10.1074/Jbc.M702278200  0.527
2005 Waxman EA, Lynch DR. N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase. The Journal of Biological Chemistry. 280: 29322-33. PMID 15967799 DOI: 10.1074/Jbc.M502080200  0.488
2005 Waxman EA, Lynch DR. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 11: 37-49. PMID 15632277 DOI: 10.1177/1073858404269012  0.525
2004 Dong YN, Waxman EA, Lynch DR. Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 11035-45. PMID 15590920 DOI: 10.1523/Jneurosci.3722-04.2004  0.524
Show low-probability matches.